DrugPatentWatch Database Preview
Details for Patent: 10,080,733
» See Plans and Pricing
Which drugs does patent 10,080,733 protect, and when does it expire?
Patent 10,080,733 protects VUMERITY and is included in one NDA.
This patent has forty-six patent family members in twenty-five countries.
Summary for Patent: 10,080,733
| Title: | Prodrugs of fumarates and their use in treating various diseases |
| Abstract: | The present invention provides compounds of formula (I), and pharmaceutical compositions thereof. ##STR00001## |
| Inventor(s): | Zeidan; Tarek A. (Lexington, MA), Duncan; Scott (Bedford, MA), Hencken; Christopher P. (Boston, MA), Wynn; Thomas Andrew (Lexington, MA), Sanrame; Carlos N. (Lexington, MA) |
| Assignee: | Alkermes Pharma Ireland Limited (Dublin, IE) |
| Application Number: | 15/782,128 |
|
Patent Claim Types: see list of patent claims | Use; Composition; Compound; |
Drugs Protected by US Patent 10,080,733
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Submissiondate |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Biogen | VUMERITY | diroximel fumarate | CAPSULE, DELAYED RELEASE;ORAL | 211855-001 | Oct 29, 2019 | RX | Yes | Yes | Start Trial | Start Trial | Y | Y | METHOD OF TREATING MULTIPLE SCLEROSIS | Start Trial | ||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Patented / Exclusive Use | >Submissiondate |
International Family Members for US Patent 10,080,733
| Country | Patent Number | Estimated Expiration | Supplementary Protection Certificate | SPC Country | SPC Expiration |
|---|---|---|---|---|---|
| Australia | 2014239641 | Start Trial | |||
| Australia | 2016222363 | Start Trial | |||
| Australia | 2018200497 | Start Trial | |||
| Brazil | 112015022854 | Start Trial | |||
| Canada | 2906580 | Start Trial | |||
| Canada | 2992211 | Start Trial | |||
| >Country | >Patent Number | >Estimated Expiration | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration |
